SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : INHL - Inhale Therapeutics - Pulmonary Insulin!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Costantino who started this subject2/9/2001 12:05:19 PM
From: semi_infinite   Read Replies (1) of 225
 
In regards to the rumors 3 weeks ago about cancer lesions spread by an unknown European source, below is an excerpt from Annals of Internal Medicine Feb. 6, 2001 Volume 134 No.3 pp.203-207.
The title of the paper is "inhaled Insulin and Type 2 Diabetes Mellitus"

>>No adverse pulmonary effects were observed in our study. In addition, 1- and 6-month studies of intrapulmonary human insulin powder were conducted in rats and cynomolgus monkeys (data on file Pfizer, Inc.). In both species, daily insulin was well tolerated and showed no signs of airway or pulmonary lesions on postmortem gross or histologic examination.<<

Can someone explain the terms gross and histologic in the last sentence and also comment on the length of the testing as to whether that's adequate.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News